To assess the clinical efficacy of Ayurvedic interventions in managing asymptomatic to mild cases of COVID-19

A prospective randomized controlled clinical trial to evaluate the efficacy and safety of Ayurvedic interventions in the management of COVID-19(Asymptomatic to moderate cases)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027346

Enrollment

Registered

2020-08-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Ayush-64, Agasthya Haritaki, Anu taila Nasal drops: AYUSH-64 500 mg Tablets Oral Twice a day 2 hrs after food Lukewarm water for 10 days Agasthya Haritaki Avleha 5 gm Oral Twice a day

Eligibility

Inclusion criteria

Inclusion criteria: Asymptomatic to moderate cases registered in the Hospital, above 18 years of age of either gender, with COVID 2019 (Confirmed by Antigen test/ RT-PCR) quarantined at our hospital. 2. Participants who can take medicines orally 3. Patients willing to provide signed informed consent

Exclusion criteria

Exclusion criteria: 1. Patients suffering from severe COVID-19 Disease as judged by a physician 2. Chronic, Severe, Unstable, Uncontrolled co-existent medical illness such as Diabetes, Hypertension, Cardiac disorders, liver, kidney disorders and lung disorders or other disease of concern which may put the patient at increased risk during the study 3. Patients who are likely to worsen or planed ICU admission or ventilator support due to any reason 4. Pregnancy and lactation 5. Participation in a drug interventional clinical drug trial of any nature in the three month period preceding onset of COVID-19 6. Participation in any other clinical trial of an experimental agent treatment for COVID-19 7. Patients on any kind of Ayurveda treatment or any other alternative and complementary medicinal systems such as Homeopathy, Unani, Siddha and in particular requiring oral therapy of any kind. 8. Physician decision that involvement in the study is not in the patient´s best interest.

Design outcomes

Primary

Measure	Time frame
1.Mean time for clinical recoveryTimepoint: 1.5th and 10th day	—

Secondary

Measure	Time frame
Changes in Laboratory and Radiological parameters (RT-PCR, CBC, ESR, LFT, RFT, BS, CRP, D-dimer, Lipid profile, HRCT chest).Timepoint: 1st 5th and 10th day	—

Countries

India

Contacts

Public ContactShikha Chaudhary

shri dhanwantry ayurvedic college and hospital

drshikha08@icloud.com9205109463

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026